GlassScriptPhysician profile
Heather Noel Cipperly
NPI 1003651324
$4,542.82
in general payments reported to CMS, 2019-2025
13 companies · $3,581 in 2025
The $3,581 reported for 2025 was more than what 95% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $961 · 2025: $3,581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,125 · Travel and Lodging: $1,704 · Consulting Fee: $300 · Entertainment: $214 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,124.70 |
| Travel and Lodging | $1,703.74 |
| Consulting Fee | $300.00 |
| Entertainment | $214.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valley Contax, INC. | $2,800.93 | 2025 | |
| Alcon Vision LLC | $418.06 | 2024-2025 | Air Optix, Rocklatan, Tryptyr |
| Johnson & Johnson Vision Care, INC. | $224.99 | 2024-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $217.30 | 2024-2025 | Xiidra, Miebo, Zenlens |
| Coopervision INC. | $209.85 | 2024 | Clariti Contact Lens |
| Tarsus Pharmaceuticals, INC. | $177.71 | 2025 | Xdemvy |
| Amgen INC. | $121.25 | 2024 | |
| Dompe US, INC. | $95.52 | 2025 | Oxervate |
| Harrow Eye, LLC | $93.44 | 2025 | Vevye |
| Carl Zeiss Meditec, INC. | $75.36 | 2024 | |
| Thea Pharma INC. | $46.19 | 2024 | Iyuzeh |
| Rxsight INC | $38.46 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Glaukos Corporation | $23.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Cipperly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.